Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies ConferenceIain C. Macdougall, Yusuke Tsukamoto, Elena Zakharova et al.|Kidney International|2016Cited by 474
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney diseaseW Bakker, J W Rood, Hiddo J.L. Heerspink et al.|Nephrology Dialysis Transplantation|2025Cited by 18